Photo of dandelion (Taraxacum officinale) by Hasan Almasi
We’re excited to share our 2025 Annual Report—a milestone year that marked a turning point for both Revive & Restore and the field of conservation biotechnology.
The Global Conservation Community Speaks
This year delivered robust validation for science-based genetic rescue. In May, 82 leading scientists from institutions spanning Stanford to the Smithsonian, the California Academy of Sciences to the University of Melbourne, signed our Shared Values statement. Their message was unequivocal: biotechnologies are additive tools for conservation that complement, rather than replace, habitat protection and species conservation.
Then, in November, the global conservation community affirmed this approach when 10,000 IUCN delegates voted 88% in favor of science-based frameworks for biotechnology in conservation, choosing evidence and collaboration over restriction.
The scale and ambition of our work reflect this momentum. This year, we’re overseeing over 70 active research projects across our genetic rescue toolkit—from stem cell technologies to genomic conservation and coral restoration.
Major milestones from 2025 include:
Stem Cell Technologies Launch: We awarded funding to seven global research teams focusing on stem cell derivation and gamete production for endangered species—opening new pathways for species that face reproductive challenges.
Biotechnology for Climate Resilience Fund: Our call for proposals, focusing on marine microbes and blue carbon ecosystems, drew a record number of submissions. We look forward to launching our first cohort of awarded projects in 2026.
Bezos Earth Fund Recognition: We were honored as one of 15 teams selected for the AI for Climate and Nature Grand Challenge. Partnering with The Rockefeller University and Cornell University, we’re developing AI tools that will democratize genome conservation worldwide.
Horseshoe Crab Conservation Progress: In November 2024, the U.S. Pharmacopeia published historic guidelines recognizing synthetic alternatives to horseshoe crab blood for drug safety testing. We launched the Sustainability Scorecard for Endotoxin Testing in May 2025, creating unprecedented transparency as the pharmaceutical industry transitions away from harvesting this ancient species.
Strategic Growth: We welcomed Emily Hatas as Vice President, bringing strategic leadership to expand our impact as conservation biotechnology continues to mature and evolve.
The Work Continues
With species disappearing at unprecedented rates, the urgency for intervention has never been greater. The global conservation community’s overwhelming support for science-based biotechnology frameworks signals a new era—one where innovation, collaboration, and shared values guide our response to the biodiversity crisis.
We invite you to explore the full report to learn more about these projects and the remarkable scientists, conservationists, and partners making this work possible.
